Welcome to MolDiag-PaCa
1. Wagner M, Seitz U, Buck A, Neumaier B, Schultheiß S, Bangerter M, Bommer M, Leithäuser F, Wawra E,
Munzert G, Reske SN. 3`[F-18]-Fluoro–3 `- Deoxythymidine ([F-18]–FLT) As Positron Emission Tomomgraphy Tracer for Imaging Proliferation in a Murine B-cell Lymphoma Model and in Human Disease. Cancer Res. 63, 2681–2687, 2003

2. Shen C, Buck AK, Liu X, Winkler M, Reske SN. Gene silencing by Adenovirus delivered siRNA. FEBS Lett. 539, 111 – 114, 2003

3. Buck AK, Schirrmeister H, Hetzel H, von der Heide M, Halter M, Glatting G, Mattfeld T, Liewald F, Reske SN, Neumaier B. F-18 FLT – PET for non-invasive assessment of proliferation in pulmonary nodules. Cancer Res 62, 3331 – 3334, 2002

4. Bunjes D, Buchmann I, Dunker C, Seitz U, Kotzerke J, Wiesneth M, Dohr D, Stefanic M, Buck AK, Harsdorf S, Glattin G, Grimminger W, Karakas T, Munzert G, Döhner H, Bergmann L,Reske SN. Rhenium–188–labeled anti–66 (a,b,c,e) monoclonal antibody to intensify conditioning regimen prior to stem cell transplantation for patients with high risk acute myeloid leukemia or myelodysplastic syndrome. Results of a phase I – II study. Bood 98, 565 – 572, 2001

5. Friesen C, Herr I, Krammer PH, Debatin K.-M. Involvement of CD 95 (Apo1/Fasreceptor/ligand system in drug induced apoptosis in leukemia cells. Nat. Med. 2, 574 – 577, 1996